Search results for "Lipids"
MKSAP Quiz: Follow-up for systemic lupus erythematosus
A 30-year-old woman is seen in follow-up. She was diagnosed with systemic lupus erythematosus 12 years ago. She was treated for lupus nephritis, which is now quiescent. What health risk assessment should be performed now?
https://immattersacp.org/weekly/archives/2022/04/05/3.htm
5 Apr 2022
Statin uptake suboptimal in PAD, industry-funded study finds
Patients with peripheral artery disease (PAD) were less likely to be taking statins than those with cerebrovascular disease or coronary heart disease, despite a high risk for atherosclerotic events.
https://immattersacp.org/weekly/archives/2020/07/14/4.htm
14 Jul 2020
Investing in EHRs pays off in paperless perks
Second in a six-part series on small practice issues.
https://immattersacp.org/archives/2008/02/ehrs.htm
1 Feb 2008
Keep up with vaccine recommendations
New vaccines and their recommendations have added complexity and made it tough to stay current. For patients, the extra costs can be prohibitive. Learn how to stay abreast of the requirements and engage patients on the issue.
https://immattersacp.org/archives/2013/09/vaccines.htm
1 Sep 2013
Cardiovascular medications underused in Hispanic/Latino patients with PAD
Efforts to improve peripheral artery disease (PAD) treatment in Hispanic/Latino populations are needed, including improved access to health care and more guideline-adherent treatment, according to the authors of a recent study.
https://immattersacp.org/weekly/archives/2020/08/11/5.htm
11 Aug 2020
Letters to the Editor
Readers respond to the ACP InternistWeekly item about lower pay driving physicians to cut their hours, and to the cover story that questioned the value of the annual physical exam.
https://immattersacp.org/archives/2010/04/letters.htm
1 Apr 2010
Omega-3 fatty acids safe, effective for reducing triglycerides
Use of omega-3 fatty acids for improving atherosclerotic cardiovascular disease risk in patients with hypertriglyceridemia is supported by a 25% reduction in major adverse cardiovascular events, according to the American Heart Association.
https://immattersacp.org/weekly/archives/2019/08/27/2.htm
27 Aug 2019
Predicting heart disease with markers is risky undertaking
Genome-wide association studies have identified at least 22 new genetic markers for CHD risk. The current debate around the value of CRP for CHD risk assessment could be considered a warm-up for things to come.
https://immattersacp.org/archives/2009/02/genomics.htm
1 Feb 2009
One intervention, many ways to explain risks
How can doctors inform patients about potential outcomes without unduly influencing their choices?.
https://immattersacp.org/archives/2008/02/risks.htm
1 Feb 2008
Sulfonylureas associated with higher CV risk than metformin
As initial monotherapy for type 2 diabetes, sulfonylureas were associated with more cardiovascular events and deaths than metformin, a new study found.
https://immattersacp.org/weekly/archives/2012/11/06/1.htm
6 Nov 2012